Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Alan F. Cowman, Lianyun Zhao et al.|Cell Host & Microbe|2020Cited by 167
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivaxAnthony N. Hodder, Alan F. Cowman, Janni Christensen et al.|Structure|2022Cited by 32
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of MalariaManuel de Lera Ruiz, John A. McCauley, Paola Favuzza et al.|ACS Medicinal Chemistry Letters|2022Cited by 26
MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Alan F. Cowman, Josephine Palandri et al.|EBioMedicine|2025Cited by 6
Basis for Drug Selectivity of Plasmepsin IX and X Inhibition for <i>Plasmodium falciparum</i> and <i>vivax</i>Anthony N. Hodder, Alan F. Cowman, Janni Christensen et al.|SSRN Electronic Journal|2021Cited by 1